ArticleScience (New York, N.Y.)2024

Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model.

Bin Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.